GLOBUS MEDICAL INC 4
4 · GLOBUS MEDICAL INC · Filed Sep 5, 2013
Insider Transaction Report
Form 4
LIPTAK ROBERT
Director10% Owner
Transactions
- Other
Class A Common Stock
2013-09-03+51,159→ 51,159 total - Other
Class A Common Stock
2013-09-03−7,244,201→ 0 total(indirect: By L.P.)
Holdings
- 7,500
Stock Option (Right to Buy Class A Common Stock)
Exercise: $12.59Exp: 2023-01-30→ Class A Common Stock (7,500 underlying) - 15,300
Stock Option (Right to Buy Class A Common Stock)
Exercise: $15.34Exp: 2022-08-29→ Class A Common Stock (15,300 underlying)
Footnotes (5)
- [F1]Distribution of shares in kind by Clarus Lifesciences I, L.P. (the "Fund") to its partners.
- [F2]Clarus Ventures I Management, L.P. ("Clarus I Management") is the sole general partner of the Fund and Clarus Ventures I, LLC ("Clarus I GPLLC") is the sole general partner of Clarus I Management. Mr. Liptak is a managing director of Clarus I GPLLC. As a managing director of Clarus I GPLLC, Mr. Liptak has shared voting and disposition power related to these shares and disclaims beneficial ownership of these shares.
- [F3]Distribution of shares in kind by the Fund. In prior reports, the Reporting Person reported that he may be deemed to beneficially own shares held of record by the Fund. As a result of the distribution of shares in kind, the Reporting Person now holds the reported shares directly.
- [F4]These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2012, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters.
- [F5]These options were granted on January 30, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.